how does glp 1 affect the brain GLP-1 mimetics and cognition The GLP-1 Dopamine Shift: Why

Efpeglenatide, initially developed as a diabetes treatment, was licensed by Hanmi to the multinational pharmaceutical company Sanofi in 2015

Flexible care model: In-person clinic in Danville plus telehealth statewide

When someone believes in you like Kelli does, you learn to believe in yourself too and then nothing feels impossible

Recent Findings The results of multiple randomized clinical trials demonstrate that, among patients with type 2 diabetes, GLP1RAs reduce body weight and improve glucose levels and lipid metabolism

95% CI, 0.55-1.01) and a 11% lower risk of all-cause mortality (21.77 vs 24.43 events per 1000 person years

J Clin Endocrinol Metab 2001;86(9):4330-4338